You can now access your Information Kit electronically, and learn about what's possible with STELARA®.
You will also receive an e-mail within the next 24 hours that contains a link to your E-kit. Click on the link to build and read your E-kit at your convenience.
To ensure you receive timely information about STELARA® and plaque psoriasis, please add firstname.lastname@example.org to your e-mail address book. In the meantime, explore our website to learn more about STELARA® and start taking advantage of all the resources available to you.
Thank you for your interest in contacting Janssen Biotech, Inc. Please note that we can only provide information about products marketed within the United States, and must refer international inquiries to our affiliates.
Janssen will be happy to answer any general product-related questions. However, we cannot recommend treatment or offer medical advice on personal health matters. If you have a question that relates to treatment of a personal medical condition, please contact your physician or healthcare professional, as this individual is most familiar with your specific medical condition and complete medical history.
If you require immediate assistance or wish to report a side effect or product complaint, Janssen Medical Information can be reached by phone at 1-800-JANSSEN (1-800-526-7736).
STELARA® is a prescription medicine approved to treat adults 18 years and older with moderate or
severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected after proper training.
STELARA® is a prescription medicineA drug that is only available with written instructions from a healthcare professional to a pharmacist. that affects your immune system. STELARA® can increase your chance of having serious side effects including:
STELARA® may lower your ability to fight infections and may increase your risk of infections. While taking STELARA®, some people have serious infections, which may require hospitalization, including tuberculosis (TB)An infectious disease, most commonly of the lungs, resulting in coughing, fever, chest pain, and weight loss., and infections caused by bacteria, fungi, or virusesGerms that grow within the body and cause a disease..
STELARA® may decrease the activity of your immune systemA system inside the body that protects against germs and infections. and increase your risk for certain types of cancer. Tell your doctor if you have ever had any type of cancer. Some people who had risk factors for skin cancer developed certain types of skin cancers while receiving STELARA®. Tell your doctor if you have any new skin growths.
RPLS is a rare condition that affects the brain and can cause death. The cause of RPLS is not known. If RPLS is found early and treated, most people recover. Tell your doctor right away if you have any new or worsening medical problems including: headache, seizures, confusion, and vision problems.
Serious allergic reactions can occur. Get medical help right away if you have any symptoms such as: feeling faint, swelling of your face, eyelids, tongue, or throat, trouble breathing, throat or chest tightness, or skin rash.
© Janssen Biotech, Inc. 2013
This site is published by Janssen Biotech Inc., which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.
The information on this site is intended for the use of patients and caregivers in the United States and Puerto Rico only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico.
Last updated November 11, 2013.